Tag Archives: Sachem Head

Elliott Advisors Has A New Target In Whitbread, Urges Spinoff Of Costa Coffee

A storm began brewing last winter for Whitbread plc (WTBCF) and its CEO Alison Brittain. Activist investor Sachem Head took a 3.4% stake in the company and began pushing for a breakup of the company. With Paul Singer’s Elliott Advisors becoming the company’s largest shareholder, it’s probably safe to upgrade that storm to hurricane status, category 5. I’m… Read More »

Spinoff Odds & Ends: New Activist At Shire $SHPG, RBR Raising Money To Fight $CS

In this edition, we provide a few updates to some of our recent articles focusing on activist activities: 1) Sachem Head vs. Shire Pharmaceuticals (SHPG) Shire Pharmaceuticals announced this summer that it was considering its ‘strategic options’, including a potential spinoff, for its neuroscience division in order to better focus on its rare diseases business. Unfortunately, the company’s stock has… Read More »